PM Earnings

PM reported its earnings on 2026-02-06, showcasing a revenue of 24.08B against an estimate of 10.41B, resulting in a 131.3% surprise. The EPS was 1.7, surpassing the expected 1.67 by 1.8%. The stock experienced a 0.45% price change on the earnings day and a 2.35% change over the next five days, reflecting market reactions to the results.

Following PM's earnings announcement on 2026-02-06, the stock price moved by 0.45% on the day of the release. Over the subsequent five days, it saw a 2.35% change. Historically, PM's stock price tends to shift by an average of -4.08% in the 10 days leading up to earnings and 1.72% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate PM's annual revenue to reach 10.21B, while the EPS is projected at 1.90. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between PM's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, PM's stock price typically moves by -4.08% in the 10 days before its earnings and 1.72% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.90 and revenue of 10.21B.

The earnings call reveals strong smoke-free product growth, particularly in the U.S. with ZYN, and a solid adjusted operating income margin. Despite some uncertainties in guidance and competitive pressures, the overall sentiment is positive due to the company's strategic focus on growth markets and innovation. The Q&A section highlighted growth opportunities in the U.S. and Japan, and the company's resilience in managing excise impacts and competition. While there are some concerns, the strategic direction and financial health suggest a positive outlook for the stock price.